Clinical Trial Update: Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131 [Phase 1]

View source ↗

Summary

A Phase 1 trial of radioimmunotherapy using the B-B4 monoclonal antibody labeled with Iodine-131 for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• B-B4 (radiolabeled with Iodine-131) (B-B4 monoclonal antibody)

Snippet

Sponsor: Centre René Gauducheau | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED